Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Islam Khalid

Over the trailing 90 days, Islam Khalid (Director at Gain Therapeutics, Inc.) bought $218K of stock across 2 companies, per 2 SEC Form 4 transactions.

Role
Director
Companies
GANX FENC
Window
Trailing 90 days · 2 transactions · CIK 1701858
Net activity
+$218K ($218K bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
FENCFENNEC PHARMACEUTICALS INC.1$218K$218K
GANXGain Therapeutics, Inc.1$0

Transactions (2)

DateSymbolTypeSharesValueDescription
2026-07-15GANXBuy25.0K$0Grant, award or other acquisition
2026-06-10FENCBuy25.0K$218KGrant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Islam's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free